Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Illumina $750 million revolving credit facility
We advised the agents and joint lead arrangers on the financing
PerkinElmer $800 million notes offering
We advised the joint bookrunners on the investment-grade debt offering
PPG $700 million notes offering
We advised the underwriters on the investment-grade debt offering
Suncor Energy $750 million senior notes offering
We advised the joint book-running managers on the investment-grade debt
Charles River Laboratories $875 million acquisition of Cognate
We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
Cleveland-Cliffs $1 billion notes offering
We advised the initial purchasers on the high-yield debt offering
PetSmart $2.35 billion notes offering
The high-yield offering involved notes due 2028 and 2029
Cleveland-Cliffs Inc. $967 million block trade
We advised the underwriter on the offering of shares
Kennedy-Wilson $1 billion notes offering
We advised the underwriters on the high-yield offering
Resideo Technologies $1.45 billion refinancing
We advised the agent and lead arrangers on the refinancing